24/7 Market News Snapshot 11 June, 2025 – Intelligent Bio Solutions Inc. Common Stock (NASDAQ:INBS)

June 11, 2025

DENVER, Colo., 11 June, 2025 (www.247marketnews.com) – (NASDAQ:INBS) are discussed in this article.
Intelligent Bio Solutions Inc. (INBS) has recently exhibited a notable surge in trading activity, opening at $1.85 and currently priced at $2.057, reflecting an impressive increase of 12.71% from the previous session close of $1.825. With a trading volume of 509.08K shares, this upward momentum points to heightened investor interest and potential for market volatility. Investors are advised to monitor broader market conditions and assess any forthcoming catalysts, as the current price trend may suggest an ongoing bullish phase for the company.

In addition to its robust trading performance, Intelligent Bio Solutions has unveiled significant strides in its strategic collaboration with SMARTOX, a prominent name in drug and alcohol screening services, aimed at enhancing its footprint in the U.S. Forensic Use Only Market. This partnership has witnessed the deployment of over 50 Intelligent Fingerprinting Drug Screening Readers, facilitating more than 7,000 screening tests, including over 1,500 conducted in 2024 alone. Such progress illustrates a rising demand for non-invasive, efficient testing solutions within forensic applications.

The Intelligent Fingerprinting Drug Screening System, which employs fingerprint sweat analysis, presents a hygienic alternative to conventional testing methods like urine and saliva sampling. By delivering rapid and reliable results, this cutting-edge technology not only streamlines the testing process but also maintains user dignity, thus improving the overall experience.

A vital component of Intelligent Bio Solutions’ growth strategy involves obtaining FDA clearance for its opiate test system targeting codeine. This clearance is essential for the anticipated expansion into broader U.S. markets, including the workplace drug testing sector by year-end.

Executive statements highlight the strategic fit of this partnership, with Doug Heath, VP of Global Sales at INBS, emphasizing the commitment to revolutionizing drug testing through innovative, non-invasive technologies, while SMARTOX’s Duffy Nabors applauds the efficiency and cost-effectiveness provided by these screenings. Intelligent Bio Solutions Inc. remains focused on advancing drug testing technology, thereby enhancing performance and user experience in both forensic and workplace environments.

Related news for (INBS)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.